Response document for the British Pharmacopoeia public consultation for characterisation of the particle population in AAV products best practice guidance
This member only document following details comments generated by members of BioPhorum Cell and Gene Therapy, following review and discussion of the draft document 'Characterisation of the Particle Population in AAV Products’. These discussions consisted of 37 cell and gene therapy subject matter experts representing 26 different Sponsors/Contract Manufacturing Organizations
I don't have access to this document
Make a selection below and submit your request. We will get back to you ASAP.
My company would like to become a member
If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.